NOVEL BLOOD-BASED BIOMARKER MODEL FOR DIAGNOSIS OF HEPATIC FIBROSIS IN MASLD

被引：0
|
作者：
Verschuren, Eveline Gart Lars [1 ]
Mak, Anne [2 ]
Boonstra, Andre [3 ]
Verheij, Joanne [4 ]
Gluud, Lise Lotte [5 ]
Holleboom, Adriaan [2 ]
Tushuizen, Maarten [6 ]
机构：
[1] TNO, The Hague, Netherlands
[2] Amsterdam UMC, Amsterdam, Netherlands
[3] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
[4] Acad Med Ctr, Amsterdam, Netherlands
[5] Univ Copenhagen, Hvidovre Hosp, Copenhagen, Denmark
[6] LUMC, Leiden, Netherlands
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2043
引用
收藏
页码：S1546 / S1547
页数：2
相关论文
共 50 条
  • [31] Predicting the Diagnosis of Prostate Cancer with a Novel Blood-Based Biomarker: Comparison of Its Performance with Prostate-Specific Antigen
    Sanders, Johnmesha L.
    Iczkowski, Kenneth A.
    Shah, Girish V.
    CANCERS, 2024, 16 (15)
  • [32] AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis
    Sterling, Richard K.
    Patel, Keyur
    Duarte-Rojo, Andres
    Asrani, Sumeet K.
    Alsawas, Mouaz
    Dranoff, Jonathan A.
    Fiel, Maria Isabel
    Murad, M. Hassan
    Leung, Daniel H.
    Levine, Deborah
    Taddei, Tamar H.
    Taouli, Bachir
    Rockey, Don C.
    HEPATOLOGY, 2025, 81 (01) : 321 - 357
  • [33] Advances in biomarker detection: Alternative approaches for blood-based biomarker detection
    Rosado, Miguel
    Silva, Rafael
    Bexiga, Mariana G.
    Jones, John G.
    Manadas, Bruno
    Anjo, Sandra I.
    ADVANCES IN CLINICAL CHEMISTRY, VOL 92, 2019, 92 : 141 - 199
  • [34] Novel blood-based, five-gene biomarker set for the detection of colorectal cancer
    Han, Mark
    Liew, Choong Tsek
    Zhang, Hong Wei
    Chao, Samuel
    Zheng, Run
    ThyeYip, Kok
    Song, Zhen-Ya
    Li, Hiu Ming
    Geng, Xiao Ping
    Zhu, Li Xin
    Lin, Jian-Jiang
    Marshall, K. Wayne
    Liew, Choong Chin
    CLINICAL CANCER RESEARCH, 2008, 14 (02) : 455 - 460
  • [35] MicroRNA-1246 as a novel candidate for a blood-based biomarker in ovarian cancer patients
    Kuhlmann, Jan Dominik
    Hahn, Stephan
    Baraniskin, Alexander
    Wimberger, Pauline
    Kasimir-Bauer, Sabine
    CANCER RESEARCH, 2012, 72
  • [36] A novel blood-based biomarker for OAC with the potential for use as an early treatment response predictor
    Lawrence, Rachel
    Swithenbank, Lucy
    Haboubi, Hasan
    Williams, Lisa
    Gwynne, Sarah
    Doak, Shareen
    Jenkins, Gareth
    BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 30 - 31
  • [37] Histone Methylation Marks on Circulating Nucleosomes as Novel Blood-Based Biomarker in Colorectal Cancer
    Gezer, Ugur
    Yoruker, Ebru E.
    Keskin, Metin
    Kulle, Cemil Burak
    Dharuman, Yoganiranjana
    Holdenrieder, Stefan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (12): : 29654 - 29662
  • [38] Discovery and validation of a novel blood-based molecular biomarker of rejection following liver transplantation
    Levitsky, Josh
    Asrani, Sumeet K.
    Schiano, Thomas
    Moss, Adyr
    Chavin, Kenneth
    Miller, Charles
    Guo, Kexin
    Zhao, Lihui
    Kandpal, Manoj
    Bridges, Nancy
    Brown, Merideth
    Armstrong, Brian
    Kurian, Sunil
    Demetris, Anthony J.
    Abecassis, Michael
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (08) : 2173 - 2183
  • [39] MicroRNA expression in extracellular vesicles as a novel blood-based biomarker for Alzheimer's disease
    Kumar, Ashish
    Su, Yixin
    Sharma, Mitu
    Singh, Sangeeta
    Kim, Susy
    Peavey, Jeremy J.
    Suerken, Cynthia K.
    Lockhart, Samuel N.
    Whitlow, Christopher T.
    Craft, Suzanne
    Hughes, Timothy M.
    Deep, Gagan
    ALZHEIMERS & DEMENTIA, 2023, 19 (11) : 4952 - 4966
  • [40] HPG80 (Progastrin), a novel blood-based biomarker for detection of neuroendocrine neoplasms
    Chauhan, Aman
    Prieur, Alexandre
    Kolesar, Jill
    Arnold, Susanne
    Cousin, Thierry
    Payen, Lea Francoise
    Sands, Madison
    Napier, Dana
    Evers, Mark
    Anthony, Lowell Brian
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345